Max Healthcare
| Company type | Public |
|---|---|
| Industry | Healthcare |
| Founded | 2000 |
| Headquarters | Delhi , India |
Area served | Northern India |
Key people | Abhay Soi (Chairman) |
| Products | Hospital network, pathology services (Max Lab), home healthcare (Max@Home) |
| Owner | Abhay Soi (sole promoter with >23% stake as of 2022) |
| Website | www |
Max Healthcare Institute Limited is a private hospital network based in Delhi, India, operating on a for-profit model. As of June 2025, the organization manages 22 hospitals with a combined capacity exceeding 5,000 beds, predominantly located in Northern India.
Beyond its hospital operations, Max Healthcare also runs Max Lab, a pathology service division, along with Max@Home, which provides home-based medical care, thereby broadening its healthcare service portfolio.
History
The inception of Max Healthcare dates back to 2000 with the opening of its inaugural medical center in Panchsheel Park, South Delhi. This was followed by the establishment of secondary care facilities in Pitampura and Noida in 2002. In 2004, the company inaugurated the East Block of its main tertiary care hospital, Max Hospital in Saket.
The expansion continued with the launch of a secondary care hospital in Gurgaon in 2007. By 2011, Max Healthcare had formed a public–private partnership with Punjab's government to develop hospitals in Mohali and Bathinda, and also opened a tertiary care facility in Shalimar Bagh, located in North West Delhi.
In 2012, Life Healthcare Group acquired a 26% ownership stake in Max Healthcare for ₹516 crore. This stake was increased to 46.41% in 2014 through an additional investment of ₹766 crore, creating an equal joint venture partnership with Max India.
The year 2015 saw Max Healthcare's acquisition of Pushpanjali Crosslay Hospital in Ghaziabad and Saket City Hospital, which were subsequently rebranded as Max Hospital Vaishali and Max Smart Hospital Saket respectively. The company further diversified by launching the standalone Max Cancer Centre oncology facility in Lajpat Nagar in 2016.
Life Healthcare exited the partnership by divesting its 49.7% shareholding in 2018. The stake was then acquired by Radiant Lifecare in 2019 for ₹2,136 crore, appointing Abhay Soi as chairman. The merger with Radiant Lifecare—owner of BLK Hospital (Delhi) and Nanavati Hospital (Mumbai)—in 2020 elevated Max Healthcare to the position of India’s second-largest healthcare provider by revenue.
Max Healthcare went public on stock exchanges in August 2020. Between 2021 and 2022, co-promoter KKR & Co. Inc. completely divested its holdings, leaving Abhay Soi as the sole promoter with a stake exceeding 23%.
In 2021, Max secured development rights for a new 500-bed hospital in Saket and acquired land for two additional hospitals in Gurgaon. It also took over management of Muthoot Hospital in Dwarka, which has a capacity of 300 beds. In the following year, it acquired majority control of Eqova Healthcare, associated with a hospital project planned for Patparganj in East Delhi.
Max Healthcare expanded into Lucknow by purchasing Sahara Hospital for ₹940 crore in December 2023. Early in 2024, it bolstered its presence in western India through the acquisition of Alexis Multi-Specialty Hospital in Nagpur for ₹412 crore.
In September 2024, Max acquired a controlling interest of 64% in Jaypee Healthcare at an enterprise valuation of ₹1,660 crore, gaining ownership over three hospitals located in Noida, Bulandshahr, and Anupshahr. By 2025, it divested from the hospitals situated in Anupshahr and Bulandshahr for ₹40 crore to concentrate on super-specialty facilities within major urban centers.
Education and research
The Max Institute of Medical Excellence (MIME) offers comprehensive training programs across various medical fields. It provides a full-time postgraduate Internal Medicine Training (IMT) course developed in collaboration with the Joint Royal College of Physicians Training Board (JRCPTB), UK. Additionally, MIME facilitates clinical education for MBBS students through an affiliation with Lincoln American University, Guyana. Training encompasses surgery, obstetrics, pediatrics, family medicine as well as specialties including gastroenterology, urology, nephrology, psychiatry, orthopedics, neurology, cardiology, and cardio-thoracic surgery.
Subsidiaries
- Max Lab delivers diagnostic and pathology services through its own and affiliated laboratories, positioning itself as the third-largest diagnostic network in northern India.
- Max@Home provides a range of services including home healthcare, nursing assistance, house visits, and medication delivery.
Controversies
In 2013, a patient passed away after reportedly receiving a defective pacemaker implant at Max Super Speciality Hospital, Mohali. Legal action was initiated in 2014 against the hospital's CEO and attending physician on charges of medical negligence and conspiracy. By 2017, the State Consumer Disputes Redressal Commission mandated compensation of ₹32.94 lakh to the deceased’s family. In 2024, the Punjab and Haryana High Court upheld summons issued to the hospital in connection with the case.
The Competition Commission of India (CCI) launched an inquiry in 2015 into Max Super Speciality Hospital, Patparganj for allegedly inflating prices on disposable syringes sold via its pharmacy outlets. The 2017 findings revealed profit margins ranging from 275% to 525%, suggesting exploitation of dominant market position across all 14 hospitals within the Max Group.
In 2016, Delhi authorities imposed a ₹600 crore fine on five hospitals, including Max Saket, for not providing legally mandated free treatment to economically disadvantaged patients despite having received concessional land allotments.
In December 2017, the Delhi government revoked the license of Max Super Speciality Hospital Shalimar Bagh after it mistakenly declared a preterm infant deceased. Subsequently, the hospital was permitted to recommence operations following a stay order on the suspension.
During the COVID-19 crisis in 2020, Max Super Speciality Hospital Patparganj faced scrutiny over treatment charges exceeding ₹1 lakh per day for critically ill patients; the hospital clarified that such fees were applicable solely to cases with extreme severity.